ROLE OF GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE IN DEPRESSION & ALCOHOLISM
3-磷酸甘油醛脱氢酶在抑郁症中的作用
基本信息
- 批准号:7720508
- 负责人:
- 金额:$ 2.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAlcohol dependenceAlcoholismApoptosisApoptoticAutopsyBindingBrainCell DeathCell LineCell NucleusCellsCessation of lifeComplexComputer Retrieval of Information on Scientific Projects DatabaseDNADataDepressed moodDiseaseEnzymesEthanolFunctional disorderFundingGenesGeneticGlutamatesGlyceraldehyde-3-Phosphate DehydrogenasesGrantGrowthHydrogen PeroxideInstitutionLeadMajor Depressive DisorderMeasuresMediatingMental DepressionMolecularMonoamine Oxidase BNeurogliaNeuronsNeurotransmittersNuclear TranslocationNumbersOxygenPathogenesisPathway interactionsPrefrontal CortexRattusRegulationReportingResearchResearch PersonnelResourcesRoleSerotoninSerotonin DegradationSignal TransductionSmall Interfering RNASourceStressSystemTestingUnited States National Institutes of Healthbrain cellbrain tissueinsightneuron lossnovelnovel therapeuticsproblem drinkerresponsestressor
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Depression and alcoholism are increasingly understood as debilitating and oftentimes fatal disorders, and co-occur more commonly than expected by chance. The molecular mechanisms contributing to observed neuronal and glial cell loss in both major depressive disorder and alcoholism remain unclear. Recent studies have focused on the apoptotic role of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a traditional glycolytic enzyme. Several groups have reported that GAPDH translocates into the cell nucleus when cells are stressed. Our preliminary data show that cell stressors or ethanol increase the expression of
GAPDH in brain-derived cell lines and also increase the binding of GAPDH with early growth response-1 (Egr-1), resulting in nuclear translocation of the GAPDH/Egr-1 complex. Treatment of brain-derived cell lines with both cell stressors and ethanol increases GAPDH expression and the interaction of GAPDH/Egr-1 more than that of treatment with cell stressors or ethanol alone. Our pilot data also demonstrate that when compared to normal control subjects, GAPDH levels are more elevated in the prefrontal cortex of subjects with co-morbid depression plus alcoholism than
in subjects with either depression or alcoholism alone. In the current application, we propose a novel GAPDHmediated
neuronal stress pathway that may involve GAPDH binding to Egr-1. Once inside the nucleus, the GAPDHEgr-1 complex separates, Egr-1 targets the monoamine oxidase B (MAO B) gene, thus increasing the expression of MAO B. MAO B then enzymatically degrades a number of neurotransmitters, producing toxic reactive oxygen (H2O2) and resulting in neuronal cell stress which promotes cell death or apoptosis.
We hypothesize that the GAPDH-Egr-1-MAO-B-mediated neuronal stress pathway contributes to the pathogenesis of depression and alcoholism and is more evident in co-morbid depression and alcoholism than in either depression or alcoholism alone. We further hypothesize that the inhibition of the GAPDH-Egr-1-MAO-Bmediated neuronal stress pathway will protect brain cells from harmful stress- and ethanol-induced effects.
Our Specific Aims are: (1) to characterize the components active in the GAPDH-Egr-1-MAO-B -mediated neuronal stress pathway by measuring the apoptotic marker (fragmented DNA) and the levels of Egr-1 and MAO B (the downstream targets of GAPDH) in the prefrontal cortex from stressed or ethanol-treated rats as compared to untreated controls; (2) to examine the expression of apoptotic markers (fragmented DNA), GAPDH and its downstream targets in postmortem brain tissue from depressed alcoholic subjects as compared to depressed subjects, alcohol-dependent subjects and normal control subjects; and (3) to disrupt the GAPDH-Egr-1-MAO-B -mediated neuronal stress pathway (using the siRNA) to test the hypothesis that inhibition of GAPDH will reduce the harmful effects of cell stressors and ethanol.
These studies are relevant to other CPN projects, because excessive glutamate signaling (Subproject 2) has been reported to trigger the GAPDH-mediated neuronal cell death cascade. The GAPDH-Egr-1-MAO-B pathway may contribute to this death cascade which causes brain cell loss in major depression (Subproject 1). Furthermore, GAPDH affects the genetic regulation of MAO, a key enzyme in degradation of serotonin. Thus, elucidating the GAPDH-Egr- 1-MAO-B -mediated neuronal stress/cell death pathway may provide new insights into serotonin system dysfunction (Subprojects 3 and 4), and might lead to novel therapeutic strategies for co-morbid depression and alcoholism.
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xiao-Ming Ou其他文献
Xiao-Ming Ou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xiao-Ming Ou', 18)}}的其他基金
Ethanol induced brain injury is decreased by inhibiting TIEG2 mediated cell death
通过抑制 TIEG2 介导的细胞死亡来减少乙醇引起的脑损伤
- 批准号:
8464911 - 财政年份:2011
- 资助金额:
$ 2.97万 - 项目类别:
PILOT PROJECT: ETOH INDUCED BRAIN INJURY DECREASED BY INHIBITING TIEG2 MEDIATED
试点项目:通过抑制 TIEG2 介导减少 ETH 引起的脑损伤
- 批准号:
8360513 - 财政年份:2011
- 资助金额:
$ 2.97万 - 项目类别:
Ethanol induced brain injury is decreased by inhibiting TIEG2 mediated cell death
通过抑制 TIEG2 介导的细胞死亡来减少乙醇引起的脑损伤
- 批准号:
8305514 - 财政年份:2011
- 资助金额:
$ 2.97万 - 项目类别:
Ethanol induced brain injury is decreased by inhibiting TIEG2 mediated cell death
通过抑制 TIEG2 介导的细胞死亡来减少乙醇引起的脑损伤
- 批准号:
8187193 - 财政年份:2011
- 资助金额:
$ 2.97万 - 项目类别:
PILOT PROJECT 1: ROLE OF GAPDH IN DEPRESSION & ALCOHOLISM
试点项目 1:GAPDH 在抑郁症中的作用
- 批准号:
8167936 - 财政年份:2010
- 资助金额:
$ 2.97万 - 项目类别:
PILOT PROJECT 1: ROLE OF GAPDH IN DEPRESSION & ALCOHOLISM
试点项目 1:GAPDH 在抑郁症中的作用
- 批准号:
7959833 - 财政年份:2009
- 资助金额:
$ 2.97万 - 项目类别:
相似海外基金
Role of glucocorticoid receptor-mediated mRNA decay in alcohol dependence
糖皮质激素受体介导的 mRNA 衰减在酒精依赖中的作用
- 批准号:
10811212 - 财政年份:2023
- 资助金额:
$ 2.97万 - 项目类别:
6/11 Astrocyte-specific changes and interventions in alcohol dependence
6/11 星形胶质细胞特异性变化和酒精依赖干预
- 批准号:
10591606 - 财政年份:2022
- 资助金额:
$ 2.97万 - 项目类别:
An Investigation of Reward Processing in Co-occurring Alcohol Dependence and Loss of Control Eating
对同时发生的酒精依赖和饮食失控的奖励处理的研究
- 批准号:
486597 - 财政年份:2022
- 资助金额:
$ 2.97万 - 项目类别:
Studentship Programs
Identifying new targets for the treatment of alcohol dependence and relapse: epigenetic analysis of the abstinent brain
确定治疗酒精依赖和复发的新靶点:戒酒大脑的表观遗传学分析
- 批准号:
10396660 - 财政年份:2022
- 资助金额:
$ 2.97万 - 项目类别:
Identifying new targets for the treatment of alcohol dependence and relapse: epigenetic analysis of the abstinent brain
确定治疗酒精依赖和复发的新靶点:戒酒大脑的表观遗传学分析
- 批准号:
10553449 - 财政年份:2022
- 资助金额:
$ 2.97万 - 项目类别:
6/11 Astrocyte-specific changes and interventions in alcohol dependence
6/11 星形胶质细胞特异性变化和酒精依赖干预
- 批准号:
10409263 - 财政年份:2022
- 资助金额:
$ 2.97万 - 项目类别:
Novel GLT-1 activators for the treatment of alcohol dependence: preclinical studies
用于治疗酒精依赖的新型 GLT-1 激活剂:临床前研究
- 批准号:
10517529 - 财政年份:2022
- 资助金额:
$ 2.97万 - 项目类别:
Reducing alcohol-seeking behavior in a rat model of alcohol dependence
减少酒精依赖大鼠模型的寻酒行为
- 批准号:
10684236 - 财政年份:2022
- 资助金额:
$ 2.97万 - 项目类别:
Opposing Contributions of Oxytocin and Corticotropin-Release Factor to Alcohol Dependence
催产素和促肾上腺皮质激素释放因子对酒精依赖的相反作用
- 批准号:
10451814 - 财政年份:2021
- 资助金额:
$ 2.97万 - 项目类别:
Opposing Contributions of Oxytocin and Corticotropin-Release Factor to Alcohol Dependence
催产素和促肾上腺皮质激素释放因子对酒精依赖的相反作用
- 批准号:
10655413 - 财政年份:2021
- 资助金额:
$ 2.97万 - 项目类别:














{{item.name}}会员




